10 stories tagged with #tempus, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Tempus"
Tempus AI: Buy On Diagnostics Momentum And AI Platform Expansion
Recent FDA approval for xT CDx's tumor-only indication and the upcoming xH assay broaden Tempus AI's clinical reach. See why TEM stock is a Strong Buy.…
Tempus AI, Inc. (TEM) Analyst/Investor Day Transcript
Tempus AI, Inc. (TEM) Analyst/Investor Day May 29, 2026 9:00 AM EDTCompany ParticipantsElizabeth Krutoholow - Vice President of Investor Relations &...…
Tempus AI, Inc. (TEM) Analyst/Investor Day - Slideshow
2026-05-30. The following slide deck was published by Tempus AI, Inc.…
Tempus AI presents multimodal foundation model results at ASCO
Tempus stock rises after FDA approval for tumor-only test
Tempus AI receives FDA approval for tumor-only genomic test
Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Tempus AI: Taking Advantage Of Investor Myopia
Tempus AI is a precision medicine leader leveraging AI and a unique data estate, with significant partnerships. Find out why TEM stock is a buy.…